| Shravan G Reddy, MD | |
|
153 Brodhead Rd, Bethlehem, PA 18017-8931 | |
| (484) 526-3218 | |
| Not Available |
| Full Name | Shravan G Reddy |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 153 Brodhead Rd, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124519087 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD475585 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Access Medical Associates Llc | 3173504388 | 2 |
| Drx Paramus, Llc | 2466589585 | 107 |
News Archive
EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions.
A week-long campaign to vaccinate more than 600,000 children against polio and measles kicks off today in Liberia...
Patients with sleep complaints but no heartburn symptoms suffered episodes of nighttime acid reflux according to research presented at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
› Verified 9 days ago
| Entity Name | St Lukes Warren Physician Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467725184 PECOS PAC ID: 9739093675 Enrollment ID: O20031117000020 |
News Archive
EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions.
A week-long campaign to vaccinate more than 600,000 children against polio and measles kicks off today in Liberia...
Patients with sleep complaints but no heartburn symptoms suffered episodes of nighttime acid reflux according to research presented at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
› Verified 9 days ago
| Entity Name | Access Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790817633 PECOS PAC ID: 3173504388 Enrollment ID: O20040526000091 |
News Archive
EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions.
A week-long campaign to vaccinate more than 600,000 children against polio and measles kicks off today in Liberia...
Patients with sleep complaints but no heartburn symptoms suffered episodes of nighttime acid reflux according to research presented at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
› Verified 9 days ago
| Entity Name | Drx Paramus, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316272685 PECOS PAC ID: 2466589585 Enrollment ID: O20100422000051 |
News Archive
EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions.
A week-long campaign to vaccinate more than 600,000 children against polio and measles kicks off today in Liberia...
Patients with sleep complaints but no heartburn symptoms suffered episodes of nighttime acid reflux according to research presented at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
› Verified 9 days ago
| Entity Name | Jersey Irish Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144575739 PECOS PAC ID: 0941451215 Enrollment ID: O20121114000210 |
News Archive
EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions.
A week-long campaign to vaccinate more than 600,000 children against polio and measles kicks off today in Liberia...
Patients with sleep complaints but no heartburn symptoms suffered episodes of nighttime acid reflux according to research presented at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shravan G Reddy, MD 801 Ostrum St, Bethlehem, PA 18015-1000 Ph: (484) 526-4000 | Shravan G Reddy, MD 153 Brodhead Rd, Bethlehem, PA 18017-8931 Ph: (484) 526-3218 |
News Archive
EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions.
A week-long campaign to vaccinate more than 600,000 children against polio and measles kicks off today in Liberia...
Patients with sleep complaints but no heartburn symptoms suffered episodes of nighttime acid reflux according to research presented at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
› Verified 9 days ago
Bram Sakdiponephong, MS, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 484-526-3555 Fax: 833-822-5230 | |
Hazem Fahmy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-6643 Fax: 484-526-4658 | |
Faton Bilali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Highland Ave, Bethlehem, PA 18020 Phone: 610-861-8080 | |
Maria Ghetu, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 610-954-3555 Fax: 610-954-3560 | |
Jose G Guzman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-6048 Fax: 484-526-6500 | |
Dr. Michael Brooks Pipestone, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, St Luke's Enrollment Center, Bethlehem, PA 18015 Phone: 484-526-3285 Fax: 484-526-6500 | |
Neil B. Matalia, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2830 Easton Ave, Bethlehem, PA 18017 Phone: 484-526-3555 Fax: 484-526-3693 |